| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/25/2004 | EP0688210B1 Use of carnosine in combination with urocanic acid for treatment of photodermatoses |
| 02/25/2004 | CN1478146A Calcium binding proteins |
| 02/25/2004 | CN1478145A Differentiated cells suitable for human therapy |
| 02/25/2004 | CN1478098A Modulation of IL-2-and IL-15-mediated T cell responses |
| 02/25/2004 | CN1478096A L-nucleic acid derivatives and processes for synthesis thereof |
| 02/25/2004 | CN1478092A Benzoxazinone derivatives, their preparation and use |
| 02/25/2004 | CN1478091A Process for preparation of taxan derivatives |
| 02/25/2004 | CN1478090A Substituted imidazopyridines |
| 02/25/2004 | CN1478089A Substituted derivatives of aminofuran-2-Y1-acetic acid and aminothien-2-Y1-acetic acid and use thereof for treating migraines and pain |
| 02/25/2004 | CN1478088A Benzothiophene derivative compounds, process of preparation and use thereof |
| 02/25/2004 | CN1478087A Indolylmaleimide derivatives as protein kinase C inibitors |
| 02/25/2004 | CN1478086A Process for crystallization of(R)-or(S)-lansoprazole |
| 02/25/2004 | CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/25/2004 | CN1478084A Compounds useful in treatment of inflammatory diseases |
| 02/25/2004 | CN1478081A Substituted 2-znilino-benzimidazoles and use thereof as NHE-inhibitors |
| 02/25/2004 | CN1478080A Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1478077A Benzamide compounds as APOB secretion inhibitors |
| 02/25/2004 | CN1478076A MCH antagonists and their use in treatment of obesity |
| 02/25/2004 | CN1478074A Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 02/25/2004 | CN1478072A Tetralone derivatives as antitumor agents |
| 02/25/2004 | CN1478067A O-substituted 6-methyl-tramadol derivatives |
| 02/25/2004 | CN1477977A Compositions of N-(methy/ethy/aminocarbony/)-4-(3-methy/pheny/amino)-3-pyridy/sulfonamide and cyclic oligosaccharides |
| 02/25/2004 | CN1477976A Combination of GABA agonists and aldose reductase inhibitors |
| 02/25/2004 | CN1477975A Combination of GABA agonists and sorbitol dehydrogenase inhibitors |
| 02/25/2004 | CN1477974A Antiobestic agents and health foods |
| 02/25/2004 | CN1477967A Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 02/25/2004 | CN1477966A Shark meat extract |
| 02/25/2004 | CN1477964A Treatment of neoplasms with viruses |
| 02/25/2004 | CN1477963A Organic compounds |
| 02/25/2004 | CN1477962A Beautifying foods and drinks and peroral beautifying preparations |
| 02/25/2004 | CN1477961A Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/25/2004 | CN1477959A Compositions and methods for lowering plasma lipoprotein (a) and risk factors of cardiovascular diseases |
| 02/25/2004 | CN1477958A Composition and method |
| 02/25/2004 | CN1477957A Tanshinone compound containing dihydrofuran ring structure for curing hyperammonemia and hepatic encephalopathy |
| 02/25/2004 | CN1477956A Crytotanshinone for preventing and delaying early senile dementia |
| 02/25/2004 | CN1477955A Parenteral dosage forms comprising suspension of tramadol salt and diclofenac salt |
| 02/25/2004 | CN1477953A Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 02/25/2004 | CN1477950A Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of critically ill, chronically ill and people with malnutrition |
| 02/25/2004 | CN1477103A Chird sugarapple lactone compound modified by ether bond, its synthesis method and application |
| 02/25/2004 | CN1477102A Sugarapple plant extract with action of resisting diabetes, medicinal application and preparation method |
| 02/25/2004 | CN1477100A Compound with activity for resisting platelet agregation and its preparation method |
| 02/25/2004 | CN1476898A Compound skeleton tablet capable of prolonging release after oral administrationi for curing common cold |
| 02/25/2004 | CN1476893A Medince composition containing huanzupulo for curing diabetes |
| 02/25/2004 | CN1476891A Chinese medicine composition for curing apoplexy and its preparation method |
| 02/25/2004 | CN1476889A Medicine for external application for curing cervical erosion |
| 02/25/2004 | CN1476868A Ointment for external application for curing scald and burn |
| 02/25/2004 | CN1476842A Fleabane extract and dicaffeoylquinic acid medicine composition and its application |
| 02/25/2004 | CN1476841A Puerarin dispersing tablet composition and its preparation method |
| 02/25/2004 | CN1476840A Preparation method of stable fleabane extract injection |
| 02/25/2004 | CN1476839A Gardenia total glycoside composite for curing hepatitis and its preparation method |
| 02/25/2004 | CN1476838A High-activity ginkgo leaf extract preparation and application |
| 02/25/2004 | CN1476837A Medicine composition |
| 02/25/2004 | CN1476836A Anti-SARS action of zizhuisongguo chrysanthemum extract and its medicine composition |
| 02/25/2004 | CN1476835A Hair follicle activating agent and its application |
| 02/25/2004 | CN1476834A Metaduocine freeze-dried powder injection preparation and its preparation method |
| 02/25/2004 | CN1476833A Preparation method of medicine for curing urteriosclerosis by using CS-866, losartan and candisartan |
| 02/25/2004 | CN1476832A Bilobalide soft capsule and its preparation method |
| 02/25/2004 | CN1476831A Biphenyl double-ester solid slowly-releasing composite |
| 02/25/2004 | CN1476830A Tea-polyphenol soft capsule and its preparation process |
| 02/25/2004 | CN1476829A Application of toosendanin as anti-tumor medicine |
| 02/25/2004 | CN1476828A Suspended preparation of biguanide vanadium complex-medicine for curing diabetes and its application |
| 02/25/2004 | CN1139597C Preparation of 9-[ 2-[ [ [di (trimethylacetoxyl) methyl] phosphoros]-methoxy-ethyl] adenine |
| 02/25/2004 | CN1139596C Crystalline amine salt of cefdinir |
| 02/25/2004 | CN1139595C Crystalline macrolides and its preparation method |
| 02/25/2004 | CN1139592C Camptothecin derivatives its preparing and use and midbody |
| 02/25/2004 | CN1139589C Tetrahydroimidazo [2,1-a] isoquinoline derivatives |
| 02/25/2004 | CN1139588C Novel fluorinated imidazoline benzodioxane, preparation and therapeutic use thereof |
| 02/25/2004 | CN1139584C Heterocyclic compounds, method for preparing and medicine composition containing same |
| 02/25/2004 | CN1139580C Substituted benzylamines and their use for treatment of depression |
| 02/25/2004 | CN1139579C Isoxazolecarboxamide derivatives |
| 02/25/2004 | CN1139572C NMDA (N-methl-D-aspartate) antagonists |
| 02/25/2004 | CN1139570C Inhibition of matrix metalloproteases by acetylene-containing compound |
| 02/25/2004 | CN1139403C Ophthalmic composition comprising beta-blocker |
| 02/25/2004 | CN1139400C Medicine for treating arthritis and bone injury disease |
| 02/25/2004 | CN1139397C Plaster for treating hyperosteogeny and osteoarthropathy and its producing method |
| 02/25/2004 | CN1139391C Medicine for dropping off drug |
| 02/25/2004 | CN1139387C Epimedium polysaccharide and its preparing method, and its application in preparing medicine for raising body's immunity |
| 02/25/2004 | CN1139386C Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
| 02/25/2004 | CN1139385C Method and composition for lipidization of hydrophilic molecules |
| 02/25/2004 | CN1139384C Therapeutic composition based on flavonoids for use in treatment of tumours with cytotoxic agents |
| 02/25/2004 | CN1139383C Therapeutic composition containing isoflavonoids for process in treatment of tumours with cytotoxic agents |
| 02/25/2004 | CN1139382C Anti-chlamydia agent |
| 02/25/2004 | CN1139381C Application of torreyaester in resisting HIV |
| 02/25/2004 | CN1139380C Water based externally used cream containing nitroglycerin, and prepn method and use thereof |
| 02/25/2004 | CN1139379C Carbocisteine composition for promoting healing of wound and burn |
| 02/25/2004 | CN1139375C Oxa diacids and related compounds for treating skin disease |
| 02/24/2004 | USRE38443 Stabilized aspirin compositions and method of preparation of oral and topical use |
| 02/24/2004 | US6696606 Solid phase synthesis of arylretinamides |
| 02/24/2004 | US6696601 Bone disorders |
| 02/24/2004 | US6696600 L-DOPA ethyl ester salts and uses thereof |
| 02/24/2004 | US6696584 For use as dietary supplement in human food and animal feeds |
| 02/24/2004 | US6696580 Steroids with a cyclohexene moiety are oxidized to the corresponding alpha, beta-unsaturated ketone that is converted to the corresponding vicinal diol using a hydroborating reagent followed by oxidative workup |
| 02/24/2004 | US6696567 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/24/2004 | US6696566 Selective p38 kinase inhibitors relative to cyclin-dependent kinases and tyrosine kinases |
| 02/24/2004 | US6696555 3'-Desoxypentopyranosyl nucleic acid, its production and its use |
| 02/24/2004 | US6696554 Production of polygalacturonides and their use as food additives |
| 02/24/2004 | US6696499 Methods and compositions for reducing or eliminating post-surgical adhesion formation |
| 02/24/2004 | US6696498 2-cyclopenten-1-one and its derivatives as inhibitors of the NF-kB factor |